These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

87 related articles for article (PubMed ID: 35546097)

  • 1. A case of adenoviral covid-19 vector vaccine possibly linked to severe but reversible interstitial lung injury post-vaccination.
    Liatsos GD; Mavroudis A; Iliakis P; Karmpalioti M; Koullias E; Vassilopoulos D
    Infect Dis (Lond); 2022 Sep; 54(9):692-697. PubMed ID: 35546097
    [TBL] [Abstract][Full Text] [Related]  

  • 2. COVID-19 Vaccine-Associated Pneumonitis in the Republic of Korea: A Nationwide Multicenter Survey.
    Yoo H; Kim SY; Park MS; Jeong SH; Park SW; Lee HL; Lee HK; Yang SH; Jegal Y; Yoo JW; Lee J; Kang HK; Choi SM; Park J; Kim YW; Song JW; Park JH; Choi WI; Choi HS; Park C; Park JW; Chung MP
    J Korean Med Sci; 2023 Apr; 38(14):e106. PubMed ID: 37038643
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Humoral response to SARS-CoV-2 adenovirus vector vaccination (ChAdOx1 nCoV-19 [AZD1222]) in heart transplant recipients aged 18 to 70 years of age.
    Tanner R; Starr N; Chan G; Dempsey E; Heffernan E; Newman E; O'Neill J; Hannan MM; Lynch B; Joyce E
    J Heart Lung Transplant; 2022 Apr; 41(4):492-500. PubMed ID: 35090809
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Superficial venous thrombosisas a possible consequence of ChAdOx1 nCoV-19 vaccine: two case reports.
    Sah MK; Singh BM; Sinha P; Devkota P; Yadav SK; Shrestha J; Shrestha A
    J Med Case Rep; 2022 May; 16(1):182. PubMed ID: 35524323
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Case Report: Cytomegalovirus Reactivation and Pericarditis Following ChAdOx1 nCoV-19 Vaccination Against SARS-CoV-2.
    Plüß M; Mese K; Kowallick JT; Schuster A; Tampe D; Tampe B
    Front Immunol; 2021; 12():784145. PubMed ID: 35116025
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Diffuse cutaneous systemic sclerosis following SARS-Co V-2 vaccination.
    Cole A; Thomas R; Goldman N; Howell K; Chakravarty K; Denton CP; Ong VH
    J Autoimmun; 2022 Apr; 128():102812. PubMed ID: 35247654
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Humoral immune response after different SARS-CoV-2 vaccination regimens.
    Rose R; Neumann F; Grobe O; Lorentz T; Fickenscher H; Krumbholz A
    BMC Med; 2022 Jan; 20(1):31. PubMed ID: 35057798
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Immune response and safety of heterologous ChAdOx1-nCoV-19/mRNA-1273 vaccination compared with homologous ChAdOx1-nCoV-19 or homologous mRNA-1273 vaccination.
    Sheng WH; Chang SY; Lin PH; Hsieh MJ; Chang HH; Cheng CY; Yang HC; Pan CF; Ieong SM; Chao TL; Chen JP; Cheng SH; Chang SC
    J Formos Med Assoc; 2022 Apr; 121(4):766-777. PubMed ID: 35305895
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Heterologous versus homologous COVID-19 booster vaccination in previous recipients of two doses of CoronaVac COVID-19 vaccine in Brazil (RHH-001): a phase 4, non-inferiority, single blind, randomised study.
    Costa Clemens SA; Weckx L; Clemens R; Almeida Mendes AV; Ramos Souza A; Silveira MBV; da Guarda SNF; de Nobrega MM; de Moraes Pinto MI; Gonzalez IGS; Salvador N; Franco MM; de Avila Mendonça RN; Queiroz Oliveira IS; de Freitas Souza BS; Fraga M; Aley P; Bibi S; Cantrell L; Dejnirattisai W; Liu X; Mongkolsapaya J; Supasa P; Screaton GR; Lambe T; Voysey M; Pollard AJ;
    Lancet; 2022 Feb; 399(10324):521-529. PubMed ID: 35074136
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Reversible radiculomyelitis after ChAdOx1 nCoV-19 vaccination.
    Spataro R; Fisco G; La Bella V
    BMJ Case Rep; 2022 Feb; 15(2):. PubMed ID: 35110289
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Acute vestibular neuritis: A rare complication after the adenoviral vector-based COVID-19 vaccine.
    Shahali H; Hamidi Farahani R; Hazrati P; Hazrati E
    J Neurovirol; 2022 Dec; 28(4-6):609-615. PubMed ID: 35877063
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Facial Angioedema after the first dose of Covishield (adenovirus-vectored severe acute respiratory syndrome coronavirus 2 vaccine): follow-up after the second and third booster doses.
    Eyer-Silva WA; Leme LSCP
    Rev Soc Bras Med Trop; 2022; 55():e00632022. PubMed ID: 35613221
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Herpes zoster following vaccination with ChAdOx1 nCoV-19 Coronavirus vaccine (recombinant).
    Job AM; Sudhamani B; Mohan M; Mohanasundaram SN
    Indian J Public Health; 2022; 66(1):83-85. PubMed ID: 35381724
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Vaccine-induced COVID-19 mimicry syndrome.
    Kowarz E; Krutzke L; Külp M; Streb P; Larghero P; Reis J; Bracharz S; Engler T; Kochanek S; Marschalek R
    Elife; 2022 Jan; 11():. PubMed ID: 35084333
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Heterologous ChAdOx1 nCoV-19 and BNT162b2 prime-boost vaccination elicits potent neutralizing antibody responses and T cell reactivity against prevalent SARS-CoV-2 variants.
    Groß R; Zanoni M; Seidel A; Conzelmann C; Gilg A; Krnavek D; Erdemci-Evin S; Mayer B; Hoffmann M; Pöhlmann S; Liu W; Hahn BH; Beil A; Kroschel J; Jahrsdörfer B; Schrezenmeier H; Kirchhoff F; Münch J; Müller JA
    EBioMedicine; 2022 Jan; 75():103761. PubMed ID: 34929493
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A randomized, double-blind, placebo-controlled phase III clinical trial to evaluate the efficacy and safety of SARS-CoV-2 vaccine (inactivated, Vero cell): a structured summary of a study protocol for a randomised controlled trial.
    Akova M; Unal S
    Trials; 2021 Apr; 22(1):276. PubMed ID: 33849629
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A Case of Heart Transplantation for Fulminant Myocarditis After ChAdOx1 nCoV-19 Vaccination.
    Kim SH; Lee SY; Kim GY; Oh JS; Kim J; Chun KJ; Ju MH; Lee CH; Song YJ; Na JY
    J Korean Med Sci; 2022 Apr; 37(13):e104. PubMed ID: 35380028
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Vaccination-associated immune thrombocytopenia possibly due to ChAdOx1 nCoV-19 (Covishield) coronavirus vaccine.
    Sivaramakrishnan P; Mishra M
    BMJ Case Rep; 2022 Mar; 15(3):. PubMed ID: 35354570
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Case Report: Severe Rhabdomyolysis and Multiorgan Failure After ChAdOx1 nCoV-19 Vaccination.
    Cirillo E; Esposito C; Giardino G; Azan G; Fecarotta S; Pittaluga S; Ruggiero L; Barretta F; Frisso G; Notarangelo LD; Pignata C
    Front Immunol; 2022; 13():845496. PubMed ID: 35371100
    [TBL] [Abstract][Full Text] [Related]  

  • 20. New relapse of multiple sclerosis and neuromyelitis optica as a potential adverse event of AstraZeneca AZD1222 vaccination for COVID-19.
    Fragoso YD; Gomes S; Gonçalves MVM; Mendes Junior E; Oliveira BES; Rocha CF; Santos GACD; Tauil CB; Araujo RV; Peron JPS
    Mult Scler Relat Disord; 2022 Jan; 57():103321. PubMed ID: 35158439
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.